Literature DB >> 15308598

Simple extraction protocol for analysis of immunosuppressant drugs in whole blood.

Thomas M Annesley1, Larry Clayton.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15308598     DOI： 10.1373/clinchem.2004.037416

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  6 in total

1.  The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles.

Authors:  Kanawat Wiwatchaitawee; Aml I Mekkawy; Juliana C Quarterman; Youssef W Naguib; Kareem Ebeid; Sean M Geary; Aliasger K Salem
Journal:  Drug Deliv Transl Res       Date:  2021-10-11       Impact factor: 5.671

2.  Impact of changing from cyclosporine to tacrolimus on pharmacokinetics of mycophenolic acid in renal transplant recipients with diabetes.

Authors:  Jeong M Park; Kathleen D Lake; Diane M Cibrik
Journal:  Ther Drug Monit       Date:  2008-10       Impact factor: 3.681

3.  Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin.

Authors:  Jaime A Yáñez; M Laird Forrest; Yusuke Ohgami; Glen S Kwon; Neal M Davies
Journal:  Cancer Chemother Pharmacol       Date:  2007-03-29       Impact factor: 3.333

4.  A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples.

Authors:  Christoph Seger; Karin Tentschert; Wolfgang Stöggl; Andrea Griesmacher; Steven L Ramsay
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

5.  Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA.

Authors:  Armin Buchwald; Karl Winkler; Thomas Epting
Journal:  BMC Clin Pharmacol       Date:  2012-01-11

6.  Multicenter analytical evaluation of the automated electrochemiluminescence immunoassay for cyclosporine.

Authors:  Michael Vogeser; Maria Shipkova; Raül Rigo-Bonnin; Pierre Wallemacq; Matthias Orth; Monika Widmann; Alain G Verstraete
Journal:  Ther Drug Monit       Date:  2014-10       Impact factor: 3.681
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.